Arthritis Care & Research

Papers
(The H4-Index of Arthritis Care & Research is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An ARChiVe Registry Cohort Study135
Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic Sclerosis92
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody–Associated Vasculitis91
Virtually Speaking: The Impact of a Nationwide Synchronous and Asynchronous Learning Forum86
Pregnancy Outcomes from a Multidisciplinary Obstetric‐Medicine/Rheumatology Clinic in the United States: A Five‐Year Retrospective Analysis73
Adipokines and Associations With Incident Osteoporotic Fracture in Patients With Rheumatoid Arthritis68
Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life?65
Association of Changes in Hand Pain With BMI, Employment, and Mental Well‐Being Over Four Years in Patients With Hand Osteoarthritis65
Issue Information63
Using Data‐Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate‐Lowering Therapy62
Physician Views and Attitudes Regarding Tobacco‐Cessation Strategies for Patients with Rheumatoid Arthritis58
Needs Assessment of Musculoskeletal Ultrasound Training in North American Pediatric Rheumatology Fellowship Programs56
Issue Information42
Clinically Relevant Subgroups Among Athletes Who Have Ruptured Their Anterior Cruciate Ligaments: A Delaware‐Oslo Cohort Study42
Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease42
Treatment of Sarcoidosis in US Rheumatology Practices: Data From the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry41
Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controll39
Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study39
Developing and Validating Methods to Assemble Systemic Lupus Erythematosus Births in the Electronic Health Record39
Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study39
Opioid Use Among Medicare Beneficiaries With Knee Osteoarthritis: Prevalence and Correlates of Chronic Use39
Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working Group38
Accuracy of diagnostic codes and algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in administrative claims and electronic health records: systematic review and meta‐a37
Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient‐Reported Outcomes and Treatment: Analysis of Real‐World Data37
Relationship Between Changing Body Mass Index and Serum Uric Acid Alteration Among Clinically Apparently Healthy Korean Men36
Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double‐Blind, Placebo‐Controlled Trial36
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases35
Baseline Dual‐Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate‐Lowering Therapy35
Cognitive Problems and Their Clinical Assessment in Systemic Lupus Erythematosus: Contrasting Patient and Provider Views35
Exploring Factors Associated with Cognitive Impairment in Rheumatoid Arthritis34
Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis32
Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide32
Reply32
0.066809892654419